# Tomita Pharmaceutical Co., Ltd. – FDA Inspection, Mar 9, 2018

Source: https://www.keypedia.com/records/fda_inspections/tomita-pharmaceutical-co-ltd/c60f41d1-194c-40a9-b100-9e28bf1526c7
Source feed: FDA_Inspections

> FDA inspection 1045598 of Tomita Pharmaceutical Co., Ltd., March 09, 2018. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1045598
- Company Name: Tomita Pharmaceutical Co., Ltd.
- Inspection Date: 2018-03-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Documents

- [FDA Inspection 1274910 - 2025-05-23](https://www.keypedia.com/records/fda_inspections/tomita-pharmaceutical-co-ltd/4f6013e3-b91f-4ff9-80dc-38c5b88386c8)
- FDA Inspection 1113539 - 2019-11-08
- FDA Inspection 981352 - 2016-07-29
- FDA Inspection 860359 - 2013-11-01
- FDA Inspection 860351 - 2013-11-01

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jason-r-caballero/c2c8d281-0d02-459f-9541-bc04cb6d0a59)
- Issuing Officer

Company: https://www.keypedia.com/companies/tomita-pharmaceutical-co-ltd/01c2e59a-b579-43f4-a73d-527ad6021b2b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c